CBX6 and chronic myelogenous leukemia, BCR-ABL1 positive: Although CBX6 has not been reported to regulate hematopoietic cell fate decisions, both CBX6 and CBX7 are suggested to be tumor suppressors in chronic myeloid leukemia (CML) [31].